Update on SCOPE trial To download click here Tuesday 28 November 2023 07:00 Categories: News Regulatory News SCIB1 Year - 2023
Scancell presents positive data from the first stage in its Phase 2 SCOPE trial at the 20th International Congress of the Society for Melanoma Research To download click here Friday 10 November 2023 09:30 Categories: Immunobody News Regulatory News SCIB1 Year - 2023
Scancell announces late-breaking abstract presenting positive data from the first stage in its Phase 2 SCOPE trial To download click here Wednesday 1 November 2023 13:00 Categories: News Regulatory News SCIB1 Year - 2023
Scancell to present at the 2023 World Vaccine Congress Europe To download click here Wednesday 18 October 2023 07:00 Categories: Modi-1 News Regulatory News SCIB1 Year - 2023
Scancell announces positive data from the first stage in its Phase 2 SCOPE trial with SCIB1 cancer vaccine delivered by needle free injection for advanced melanoma To download click here Tuesday 19 September 2023 07:00 Categories: News Regulatory News SCIB1 Year - 2023
Pipeline strategy and business update To download click here Monday 10 July 2023 11:58 Categories: Modi-1 News Regulatory News SCIB1 Year - 2023
Phase 2 SCOPE trial of SCIB1 vaccine in metastatic melanoma patients expanded To download click here Wednesday 15 June 2022 11:03 Categories: News Regulatory News SCIB1 Year - 2022
First patient dosed in SCIB1 Phase 2 clinical trial To download click here Friday 19 November 2021 08:20 Categories: News Regulatory News SCIB1 Year - 2021
SCIB1 IND application approved To download click here Monday 3 February 2020 09:00 Categories: News Regulatory News SCIB1 Year - 2020
Scancell Interim Results To download click here Friday 31 January 2020 10:00 Categories: AvidiMab Modi-1 Moditope News Regulatory News SCIB1 SCIB2 Year - 2020